Associate Director, US Commercial Insights at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, OncologyIndustries

Requirements

Bachelor’s degree in Business, Life Sciences, Statistics, or similar; advanced degree preferred
7+ years in pharma / biotech market research, analytics and / or consulting
Proficiency with third-party data sources, including patient-level and sales data, and tools for analysis/visualization (Excel, Tableau, Power BI)
Direct experience designing and executing market research projects
Strong communication skills with a track record of influencing stakeholders in global, matrixed environments
Travel Required: 25% as required
Preferred Qualifications
Oncology or rare disease experience, strong preference for prior experience in radiopharmaceuticals
Hands-on analytics experience (SQL, R, Python)
Prior launch experience

Responsibilities

Plan, lead and own US insight generation, including analytics and market research, for RYZ 101’s planned US launch in gastroenteropancreatic neuroendocrine tumors (GEP-NET)
Procure and leverage third-party data to generate insights on patient journey, demand trends and promotional impact
Partner with RayzeBio’s business operations team to compliantly integrate and analyze third-party data sources with internal operations data to generate detailed insights on patient experience, HCP experience and product delivery
Develop and deliver dashboards to monitor sales performance and critical key performance indicators (KPIs)
Design and execute a comprehensive primary market research plan (quantitative and qualitative) to support pre-launch strategic and tactical planning and post-launch tracking
Manage market research and analytics vendors to ensure quality, compliance and timely execution
Collaborate cross-functionally with medical, HEOR, access, data strategy, sales operations and finance to develop integrated, insight-driven recommendations
Oversee adherence to SOPs, GDPR and applicable global / local compliance standards

Skills

Market Research

Commercial Analytics

Insight Generation

Data Analytics

Third-Party Data

Patient Journey

Demand Trends

Promotional Impact

US Launch Planning

Cross-Functional Collaboration

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free